EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SCN5A U12‐Type Minor Intron Variant Causes Cryptic Splicing and Cardiac Arrhythmia Disease

Emma S Singer iD, Serena Li iD, Ginell N Ranpura iD, Seakcheng Lim iD, Sean Lal iD, Adam M Bournazos iD, Sandra T Cooper iD, Zachary Laksman, Richard D Bagnall iD

Human Mutation · 2026

DOI: 10.1155/humu/4537601 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, 2026. Verfasst von Emma S Singer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Bioinformatics and Molecular Genetics Group at Centenary Institute, The University of Sydney, Sydney, New South Wales, Australia, sydney.edu.au. Hauptthemen laut MEDLINE: Introns, NAV1.5 Voltage-Gated Sodium Channel, Arrhythmias, Cardiac, RNA Splicing. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NSW Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Variants affecting minor (U12‐type) intron splice sites are underreported, and their consequences are poorly understood, which makes predicting their pathogenicity challenging. We investigated the impact on splicing of an SCN5A minor intron donor variant in an individual with cardiac arrhythmias using patient‐specific induced pluripotent stem cell cardiomyocytes (iPSC‐CMs). Genetic testing in the proband identified an SCN5A c.392+3A>G variant of uncertain significance in a minor intron donor splice site, which segregated in affected family members with cardiac phenotypes, including Brugada syndrome. Transcriptome sequencing of proband‐specific iPSC‐CMs, treated with and without inhibition of nonsense‐mediated decay, revealed aberrant SCN5A splicing. Four variant‐associated isoforms were absent from control iPSC‐CMs and control myectomy samples, and one skipped Exon 3 with a 96 bp extension of Exon 4. All alternatively spliced SCN5A transcripts were T/A cloned and confirmed by Sanger sequencing. These alternatively spliced transcripts used novel combinations of cryptic minor and major splice sites and introduced premature termination codons or an in‐frame deletion, supporting reclassification of the variant as likely pathogenic. A genome‐wide analysis of SpliceAI scores across minor intron splice sites retrieved from the Minor Intron Database revealed clear patterns of variants with high predicted splicing impact. This analysis also highlighted distinct splice site sequence motifs between minor and major splice sites that are not currently considered in ACMG/AMP variant interpretation guidelines. We further demonstrate that some cryptic donor–acceptor motif pairings are likely incompatible with splicing, which may inform future improvements in in silico splice site prediction tools. Integrating functional RNA sequencing with SpliceAI‐based predictions at minor introns offers a pathway towards refining variant interpretation frameworks in clinical genomics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IntronsNAV1.5 Voltage-Gated Sodium ChannelArrhythmias, CardiacRNA SplicingHumansRNA Splice SitesAlternative SplicingInduced Pluripotent Stem CellsPedigreeFemaleMyocytes, CardiacBrugada SyndromeMutationExonsPhenotype

Stichwörter der Autor:innen

Brugada syndromeRNA splicinggenetic heart diseaseinduced pluripotent stem cellsminor introns

Substanzen

NAV1.5 Voltage-Gated Sodium ChannelSCN5A protein, humanRNA Splice Sites

Autor:innen und Institutionen

  • Bioinformatics and Molecular Genetics Group at Centenary Institute, The University of Sydney, Sydney, New South Wales, Australia, sydney.edu.au.
  • Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia, sydney.edu.au.
  • Molecular Cardiology Program at Centenary Institute, The University of Sydney, Sydney, New South Wales, Australia, sydney.edu.au.
  • Kids Neuroscience Centre, Children's Hospital at Westmead, Westmead, New South Wales, Australia.
  • Neuromuscular Gene Discovery Group, Children's Medical Research Institute, Westmead, New South Wales, Australia.
  • Centre for Heart Lung Innovation, University of British Columbia, Vancouver, Canada, ubc.ca.

ORCID-Profile: Emma S Singer, Serena Li, Ginell N Ranpura, Seakcheng Lim, Sean Lal, Adam M Bournazos, Sandra T Cooper, Richard D Bagnall

Förderung

  • NSW Health

Zitieren

APA

Singer, E. S., Li, S., Ranpura, G. N., Lim, S., Lal, S., Bournazos, A. M., Cooper, S. T., Laksman, Z., & Bagnall, R. D. (2026). SCN5A U12‐Type Minor Intron Variant Causes Cryptic Splicing and Cardiac Arrhythmia Disease. Human Mutation. https://doi.org/10.1155/humu/4537601

Vancouver

Singer ES, Li S, Ranpura GN, Lim S, Lal S, Bournazos AM, et al. SCN5A U12‐Type Minor Intron Variant Causes Cryptic Splicing and Cardiac Arrhythmia Disease. Human Mutation. 2026. doi:10.1155/humu/4537601

BibTeX
@article{Singer2026,
  author = {Singer, Emma S and Li, Serena and Ranpura, Ginell N and Lim, Seakcheng and Lal, Sean and Bournazos, Adam M and Cooper, Sandra T and Laksman, Zachary and Bagnall, Richard D},
  title = {SCN5A U12‐Type Minor Intron Variant Causes Cryptic Splicing and Cardiac Arrhythmia Disease},
  journal = {Human Mutation},
  year = {2026},
  doi = {10.1155/humu/4537601}
}
Kostenlos starten →